心理心理因素之间的因果关系,如压力,焦虑,抑郁症和易怒肠综合征:孟德尔的随机化
Zhihao Diao1, Wenchang Xu1, Danyang Guo2
1School of Acupuncture and Tuina, Shandong University of Traditional Chinese Medicine, Jinan, China.
Medicine
|September 1, 2023
概括
压力,焦虑和抑郁等心理健康状况是刺激性肠综合征 (IBS) 的原因因素. 这项研究使用门德尔的随机化来证实这些联系,为IBS治疗提供了洞察力.
科学领域:
- 遗传学和流行病学
- 胃肠病学 胃肠病学
- 精神病学是一个精神病学.
背景情况:
- 刺激性肠综合征 (IBS) 提出了诊断和治疗方面的挑战.
- 观察性研究将IBS与诸如压力,焦虑和抑郁等心理健康状况联系起来.
- 心理健康和IBS之间的因果关系需要进一步调查.
研究的目的:
- 使用孟德尔随机化 (MR) 调查心理健康因素 (压力,焦虑,抑郁) 和IBS之间的因果关系.
- 进行双向MR分析,检查精神健康作为IBS的原因和IBS作为精神健康状况的原因.
主要方法:
- 利用两样本的门德尔随机化 (MR) 方法与公开可用的全基因组关联研究数据.
- 采用逆方差加权 (IVW) 方法作为主要分析技术.
- 进行了敏感性分析,以确保调查结果的可靠性.
主要成果:
- 包括压力,焦虑和抑郁在内的心理健康因素被确定为IBS的潜在病因 (OR=1.06,95%CI:1.03-1.08).
- 单变量分析显示了显著的正相关性:抑郁症 (OR=1.31,P=0.016) 和焦虑症 (OR=1.53,P=0.003).
- 反向MR分析表明IBS对心理健康因素没有因果作用 (P>0.05).
结论:
- 精神和心理因素被证实是IBS的潜在原因.
- 研究结果表明,解决心理健康问题可能对有效的IBS临床管理至关重要.
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
311
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
311
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
188
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
188
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
240
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
240
01:17Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
354
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354
01:17Drugs for Treatment of Diarrhea-Predominant IBS
209
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
209